# TRIC-A Loss Sensitizes the Heart to β-Adrenergic Stress and Drives Cardiomyocyte Death and Fibrosis

**Authors:** Ki Ho Park, Daiju Yamazaki, Xinyu Zhou, Shinji Komazaki, Chengzhu Zhao, Miyuki Nishi, Jingsong Zhou, Hiroshi Takeshima, Jianjie Ma

PMC · DOI: 10.3390/biom16020181 · Biomolecules · 2026-01-23

## TL;DR

TRIC-A protects the heart from stress-induced damage by regulating calcium balance and preventing cell death and fibrosis.

## Contribution

This study identifies TRIC-A as a critical regulator of cardiac resilience during β-adrenergic stress.

## Key findings

- TRIC-A deficiency leads to SR Ca2+ overload and mitochondrial damage during β-adrenergic stimulation.
- Mitochondrial Ca2+ overload is the proximal trigger of cardiomyocyte necrosis in Tric-a−/− hearts.
- TRIC-A loss causes fibrosis without hypertrophy, driven by cardiomyocyte injury rather than fibroblast dysfunction.

## Abstract

Trimeric intracellular cation channel A (TRIC-A) provides counter-ion support for sarcoplasmic reticulum (SR) Ca2+ release, yet its physiological role in the intact heart under stress remains poorly defined. Here, we demonstrate that TRIC-A is essential for maintaining balanced SR Ca2+ release, mitochondrial integrity, and cardiac resilience during β-adrenergic stimulation. Tric-a−/− cardiomyocytes exhibited Ca2+ transients evoked by electrical stimuli and exaggerated isoproterenol (ISO)-evoked Ca2+ release, consistent with SR Ca2+ overload. These defects were accompanied by selective upregulation of protein kinase A (PKA)-dependent phosphorylation of ryanodine receptor 2 (RyR2) (S2808) and phospholamban (PLB) (S16). Acute ISO challenge induced mitochondrial swelling, cristae disruption, and Evans Blue Dye uptake, and elevated circulating troponin T in Tric-a−/− hearts, hallmarks of necrosis-like cell death. Mitochondrial Ca2+ uptake inhibition with Ru360 markedly reduced membrane injury, establishing mitochondrial Ca2+ overload as the proximal trigger of cardiac cell death. With sustained β-adrenergic stimulation by ISO, Tric-a−/− hearts developed extensive interstitial and perivascular fibrosis without exaggerated hypertrophy. Cardiac fibroblasts lacked TRIC-A expression and displayed normal Ca2+ signaling and activation, indicating that fibrosis arises secondarily from cardiomyocyte injury rather than fibroblast-intrinsic abnormalities. These findings identify TRIC-A as a critical regulator of SR-mitochondrial Ca2+ coupling and a key molecular safeguard that protects the heart from catecholamine-induced injury and maladaptive remodeling.

## Linked entities

- **Genes:** TMEM38A (transmembrane protein 38A) [NCBI Gene 79041], RYR2 (ryanodine receptor 2) [NCBI Gene 6262], PLN (phospholamban) [NCBI Gene 5350]
- **Proteins:** TMEM38A (transmembrane protein 38A)
- **Chemicals:** isoproterenol (PubChem CID 3779), Ru360 (PubChem CID 171663342), Evans Blue Dye (PubChem CID 9566057)
- **Diseases:** cardiomyopathy (MONDO:0004994)

## Full-text entities

- **Genes:** Ccn2 (cellular communication network factor 2) [NCBI Gene 14219] {aka Ctgf, Fisp12, Hcs24, fisp-12}, Agt (angiotensinogen) [NCBI Gene 11606] {aka AngI, AngII, Aogen, Serpina8}, Mcu (mitochondrial calcium uniporter) [NCBI Gene 215999] {aka 2010012O16Rik, C10orf42, Ccdc109a, D130073L02Rik, Gm64}, TMEM38A (transmembrane protein 38A) [NCBI Gene 79041] {aka TRIC-A, TRICA}, Cacna1c (calcium channel, voltage-dependent, L type, alpha 1C subunit) [NCBI Gene 12288] {aka Cav1.2, Cchl1a1, D930026N18Rik, MBC, MELC-CC}, PLN (phospholamban) [NCBI Gene 5350] {aka CMD1P, CMH18, PLB}, Ryr2 (ryanodine receptor 2, cardiac) [NCBI Gene 20191] {aka 9330127I20Rik, RYR-2}, Myh6 (myosin, heavy polypeptide 6, cardiac muscle, alpha) [NCBI Gene 17888] {aka A830009F23Rik, Myhc-a, Myhca, alpha-MHC, alphaMHC}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, TMEM38B (transmembrane protein 38B) [NCBI Gene 55151] {aka C9orf87, D4Ertd89e, OI14, TRIC-B, TRICB, bA219P18.1}, MARVELD2 (MARVEL domain containing 2) [NCBI Gene 153562] {aka DFNB49, MARVD2, MRVLDC2, Tric}, Nppb (natriuretic peptide type B) [NCBI Gene 18158] {aka BNF, BNP, Iso-ANP}, Tlx2 (T cell leukemia, homeobox 2) [NCBI Gene 21909] {aka Enx, Hox11L.1, Hox11l1, NCX, Ncx1, Tlx1l1}, Tmem38a (transmembrane protein 38A) [NCBI Gene 74166] {aka 1110001E17Rik, SPR-27, TRIC-A, mg33a}, Tmem38b (transmembrane protein 38B) [NCBI Gene 52076] {aka 1600017F22Rik, D4Ertd89e, TRIC-B, mg33b}, Itpr2 (inositol 1,4,5-triphosphate receptor 2) [NCBI Gene 16439] {aka InsP3R-2, InsP3R-5, Ip3r2, Itpr5, insP3R2}, Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, Mmp3 (matrix metallopeptidase 3) [NCBI Gene 17392] {aka EMS-2, MMP-3, SL-1, SLN-1, SLN1, STR-1}, ITPR3 (inositol 1,4,5-trisphosphate receptor type 3) [NCBI Gene 3710] {aka CMT1J, IMD132, IMD133, IP3R, IP3R-3, IP3R3}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, Camk2b (calcium/calmodulin-dependent protein kinase II, beta) [NCBI Gene 12323] {aka CaMKII}, Casq1 (calsequestrin 1) [NCBI Gene 12372] {aka CSQ, CSQ-1, CSQ1, sCSQ}, Jph2 (junctophilin 2) [NCBI Gene 59091] {aka 1110002E14Rik, JP-2, Jp2}, Pln (phospholamban) [NCBI Gene 18821] {aka Plb}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Nppa (natriuretic peptide type A) [NCBI Gene 230899] {aka ANP, Anf, CDD, Pnd}, Atp2a2 (ATPase, Ca++ transporting, cardiac muscle, slow twitch 2) [NCBI Gene 11938] {aka 9530097L16Rik, D5Wsu150e, SERCA2, SERCA2B, Serca2a, mKIAA4195}
- **Diseases:** TRIC-A Deficiency (MESH:D015270), necrosis (MESH:D009336), Emery-Dreifuss muscular dystrophy (MESH:D020389), hypertrophic remodeling (MESH:D020257), muscle disorders (MESH:D009135), hypertrophic (MESH:D002312), cardiomyopathies (MESH:D009202), cardiac hypertrophic (MESH:D006331), SR (MESH:D008228), membrane injury (MESH:D015433), respiratory failure (MESH:D012131), arrhythmogenic disorders (MESH:D019571), heart failure (MESH:D006333), bone defects (MESH:D001847), osteogenesis imperfecta (MESH:D010013), swelling (MESH:D004487), catastrophic failure (MESH:D051437), hypertrophy (MESH:D006984), Cardiomyocyte Death (MESH:D003643), hypertension (MESH:D006973), Mitochondrial Injury (MESH:D028361), Takotsubo syndrome (MESH:D054549), embryonic lethality (MESH:D020964), Cardiomyocyte injury (MESH:D014947), Fibrosis (MESH:D005355)
- **Chemicals:** Toluidine blue (MESH:D014048), glucose (MESH:D005947), formalin (MESH:D005557), ethanol (MESH:D000431), CaCl2 (MESH:D002122), glutaraldehyde (MESH:D005976), KCl (MESH:D011189), eosin (MESH:D004801), Fura-2 (MESH:D016257), PVDF (MESH:C024865), SDS (MESH:D012967), isoflurane (MESH:D007530), Evans Blue (MESH:D005070), ATP (MESH:D000255), ISO (MESH:D007545), taurine (MESH:D013654), Fura-2 AM (MESH:C049925), uranyl acetate (MESH:C005460), epoxy resin (MESH:D004853), xylene (MESH:D014992), PE (MESH:D010656), Ru360 (MESH:C112020), catecholamine (MESH:D002395), MTT (MESH:C070243), K+ (MESH:D011188), phosphate (MESH:D010710), HEPES (MESH:D006531), osmium tetroxide (MESH:D009993), Hematoxylin (MESH:D006416), caffeine (MESH:D002110), IM (MESH:D015759), paraffin (MESH:D010232), Ca2+ (-), MgCl2 (MESH:D015636), Indo-1 (MESH:C048960), platinum (MESH:D010984), NaCl (MESH:D012965), H&amp;E (MESH:D006371), TG (MESH:D019284)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** R14del
- **Cell lines:** ACC-003 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_6872), PA5- — Gallus gallus (Chicken), Marek disease, Cancer cell line (CVCL_T629), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), HT15 — Mus musculus (Mouse), Hybridoma (CVCL_J689)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937667/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937667/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937667/full.md

---
Source: https://tomesphere.com/paper/PMC12937667